30501481Woyach JA, Ruppert AS, Heerema NA, Zhao W, Booth AM, Ding W, Bartlett NL, Brander DM, Barr PM, Rogers KA, Parikh SA, Coutre S, Hurria A, Brown JR, Lozanski G, Blachly JS, Ozer HG, Major-Elechi B, Fruth B, Nattam S, Larson RA, Erba H, Litzow M, Owen C, Kuzma C, Abramson JS, Little RF, Smith SE, Stone RM, Mandrekar SJ, Byrd JCThe New England journal of medicineBendamustine Hydrochloride; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Pyrazoles; Pyrimidines; RituximabAdenine; Aged; Aged, 80 and over; Drug Therapy, Combination; Female; Follow-Up Studies; Hematologic Diseases; Humans; Male; Piperidines; Progression-Free Survival; Survival AnalysisIbrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL. N Engl J Med. 2018 12 27; 379(26):2517-2528.N Engl J Med2018-12-01T00:00:002018Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000225Chemicals & Drugs41850.953076AdenineD000369Living Beings93664810.461294Aged, 80 and overD000368Living Beings1341183530.294764AgedD004359Procedures2748930.819188Drug Therapy, CombinationAuthorship 126131210.172870.172871authors10.2517has subject areaD006402Disorders56790.958522Hematologic DiseasesD007167Procedures1836270.665954ImmunotherapyD005260Physiology1992444050.191167FemaleD006801Living Beings2262862810.130052HumansD015451Disorders571360.907606Leukemia, Lymphocytic, Chronic, B-CellD008297Physiology1931408600.201617MaleMedicine-Hematology and OncologyD010880Chemicals & Drugs951810.872271PiperidinesD011720Chemicals & Drugs841530.896041PyrazolesD011743Chemicals & Drugs1373700.795259PyrimidinesD016019Concepts & Ideas43415360.742907Survival AnalysisD000069283671160.945252RituximabD000069461580.995792Bendamustine HydrochlorideD005500Procedures76836160.590107Follow-Up StudiesUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.Professortrue1ProfessorProfessor